
2010
	First		Second(1)		Third		Fourth(2)
	(in thousands, except per share results)
Total revenues	$	8,380,338	$	8,589,243	$	8,350,812	$	8,276,442
Income before income taxes		416,926		535,854		622,290		174,492
Net income		258,768		340,076		393,221		107,325
Basic earnings per common share		1.54		2.02		2.35		0.64
Diluted earnings per common share		1.52		2.00		2.32		0.63

	2009
	First		Second		Third		Fourth
	(in thousands, except per share results)
Total revenues	$	7,662,986	$	7,842,909	$	7,657,773	$	7,578,907
Income before income taxes		293,762		439,950		469,348		398,700
Net income		205,717		281,780		301,519		250,659
Basic earnings per common share		1.23		1.68		1.80		1.49
Diluted earnings per common share		1.22		1.67		1.78		1.48

(1)	Includes an expense of $147.5 million ($93.4 million after tax, or $0.55 per diluted common share) for the write-down of deferred acquisition costs associated with our individual major medical policies as more fully described in Note 18 to the consolidated financial statements.

(2)

Includes an expense of $138.9 million ($88.0 million after tax, or $0.52 per diluted common share) associated with reserve strengthening for our closed block of long-term care policies acquired in connection with the 2007 acquisition of KMG America Corporation as more fully described in Note 18 to the consolidated financial statements.